RVL Pharmaceuticals plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVLP research report →
About the company
RVL Pharmaceuticals plc operates as a specialized pharmaceutical firm, concentrating on the creation and commercialization of medicinal products. These offerings target patient populations with unmet needs within the fields of ocular health and medical aesthetics across the United States, Argentina, and Hungary. Among its key commercialized products is Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution specifically developed for adults experiencing acquired blepharoptosis, or drooping eyelids.
- CEO
- Brian A. Markison
- IPO
- 2018
- Employees
- 125
- HQ
- Bridgewater, NJ, US
Price Chart
- Market Cap
- $3.14M
- P/E
- -0.05
- P/S
- 0.06
- P/B
- 0.05
- EV/EBITDA
- -0.44
- Div Yield
- 0.00%
- Gross Margin
- 80.98%
- Op Margin
- -91.87%
- Net Margin
- -103.96%
- ROE
- -80.88%
- ROIC
- -41.26%
- Revenue
- $49.72M · 184.10%
- Net Income
- $-51,692,000 · 37.61%
- EPS
- $-0.58 · 52.85%
- Op Income
- $-45,680,000
- FCF YoY
- 31.77%
- 52W High
- $1.66
- 52W Low
- $0.00
- 50D MA
- $0.09
- 200D MA
- $0.66
- Beta
- 1.09
- Avg Volume
- 24.42M
Get TickerSpark's AI analysis on RVLP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 19, 23 | Harsaul Foundation | sell | 9,363,760 |
| Oct 20, 23 | Harsaul Foundation | sell | 4,758,899 |
| Oct 19, 23 | Altchem Ltd | sell | 9,363,760 |
| Oct 20, 23 | Altchem Ltd | sell | 4,758,899 |
| Oct 18, 23 | Harsaul Foundation | sell | 3,421,537 |
| Oct 18, 23 | Altchem Ltd | sell | 3,421,537 |
| Aug 15, 23 | Avista Healthcare Partners GP, Ltd. | other | 23,730,864 |
| Aug 10, 23 | Lask Alisa | other | 12,000 |
| Jul 5, 23 | DeBiasi Michael J. | other | 40,000 |
| Jul 5, 23 | COWAN GREGORY L | other | 40,000 |
Our RVLP coverage
Recent articles, reports, and earnings notes.
No research on RVLP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RVLP report →Similar companies
Peers in the same neighborhood.